Journal
NEUROPHARMACOLOGY
Volume 61, Issue 8, Pages 1406-1412Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2011.08.030
Keywords
Alzheimer's disease; Dementia; Ethanol; Phospholipase A(2); Synapses; Synaptophysin
Categories
Funding
- European Commission
Ask authors/readers for more resources
The loss of synapses and a corresponding reduction in synaptic proteins are histopathological features of Alzheimer's disease that correlate strongly with dementia. Here we report that stable A beta oligomers secreted by 7PA2 cells reduced the amount of synaptophysin, a protein used as an indicator of synapse density, in cultured cortical and hippocampal neurons. Pre-treatment with physiologically relevant concentrations of ethanol (0.02-0.08%) protected neurons against A beta-induced synapse damage. Ethanol also protected neurons against synapse damage induced by alpha-synuclein (alpha SN), pre-synaptic aggregates of which are characteristic of Parkinson's disease and dementia with Lewy bodies. Exposure of neurons to ethanol did not affect the accumulation of A beta at synapses, rather it reduced the A beta and alpha SN-induced activation of cytoplasmic phospholipase A(2) (cPLA(2)) within synapses. Ethanol did not affect synapse damage caused by platelet-activating factor or prostaglandin E(2), bioactive lipids that are formed following the activation of cPLA2. These results may help explain epidemiological reports that moderate alcohol consumption protects against the development of dementia in Alzheimer's and Parkinson's diseases. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available